Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

93
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
93
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

101
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
101
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

183
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
183
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

124
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
124
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

391
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
391
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

706
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
706

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Association of Non-invasive Ventilation and Mortality in COVID-19 Induced Acute Respiratory Distress Syndrome.

Journal of community hospital internal medicine perspectivesยท2025
Same author

Single-center outcomes of artificial intelligence in management of pulmonary embolism and pulmonary embolism response team activation.

Journal of investigative medicine : the official publication of the American Federation for Clinical Researchยท2024
Same author

Lupus Enteritis in the Absence of a Lupus Flare. A Case Report and Review of Literature.

Journal of community hospital internal medicine perspectivesยท2023
Same author

Evidence-based Role of Aspirin in Giant Cell Arteritis: A Literature Review.

Journal of community hospital internal medicine perspectivesยท2022
Same author

Baffling Case of a Patient With History of Lupus in a COVID-19 Pandemic.

Journal of community hospital internal medicine perspectivesยท2022
Same author

Atypical Lemierre's Syndrome. A Case Report and Review of Literature.

Journal of community hospital internal medicine perspectivesยท2022

Related Experiment Video

Updated: Nov 8, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

24.7K

Atypical Pyoderma gangrenosum: a case of delayed recognition.

Anum Qureshi1, Kia Persaud1, Sajida Zulfiqar1

  • 1Department of Internal Medicine, Greater Baltimore Medical Center, Towson, MD, USA.

Journal of Community Hospital Internal Medicine Perspectives
|April 23, 2021
PubMed
Summary

Pyoderma gangrenosum (PG) is a challenging inflammatory skin disease often mistaken for infections. Prompt diagnosis and collaborative treatment are key for better patient outcomes and reduced scarring.

Keywords:
Pyoderma gangrenosumcellulitisglucocorticoidspathergy

More Related Videos

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection
06:56

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

Published on: February 20, 2020

8.8K

Related Experiment Videos

Last Updated: Nov 8, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

24.7K
A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection
06:56

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

Published on: February 20, 2020

8.8K

Area of Science:

  • Dermatology
  • Immunology
  • Pathology

Background:

  • Pyoderma gangrenosum (PG) is a rare, neutrophilic dermatosis characterized by painful ulcerative lesions.
  • It is frequently misdiagnosed, often confused with infectious etiologies like necrotizing infections.
  • Underlying systemic diseases are common in patients presenting with PG.

Observation:

  • Patients with systemic disease presenting with large, non-healing ulcerating lesions require consideration for PG.
  • Lesions unresponsive to antibiotic therapy warrant further investigation for alternative diagnoses.
  • The clinical presentation can mimic other ulcerative conditions, complicating diagnosis.

Findings:

  • Early and accurate diagnosis of pyoderma gangrenosum is critical for effective management.
  • A multidisciplinary approach involving dermatology, surgery, and internal medicine is often necessary.
  • Timely intervention can prevent disease progression and secondary complications.

Implications:

  • Improved quality of life for patients suffering from this debilitating skin condition.
  • Minimization of significant cosmetic morbidity associated with extensive ulceration and scarring.
  • Enhanced understanding of PG can lead to more targeted and effective therapeutic strategies.